In the context of cancer treatment, flexible inclusion criteria can be crucial for several reasons:
Enhanced Patient Access: Patients with diverse characteristics, including those with rare or advanced cancers, can gain access to innovative treatments. Improved Generalizability: Findings from studies with flexible inclusion criteria are often more applicable to the general population, making the results more valuable for clinical practice. Accelerated Recruitment: Broad criteria can speed up the recruitment process, essential for timely completion of trials.
